Lepu Biopharma Valuation Multiples

Lepu Biopharma Overview

About Lepu Biopharma

Lepu Biopharma Co Ltd is a biopharmaceutical company focusing on oncology therapeutics and has one operating segment. The Group is principally engaged in the sales of pharmaceutical products and the research and development of new drugs. The majority operating entity of the Group is domiciled in Mainland China. The company has established an integrated end-to-end platform across drug discovery, clinical development, CMC, and GMP-compliant manufacturing, encompassing all critical functions of the biopharmaceutical value chain. The company generates the majority of its revenue from the Sale of pharmaceutical products. The company also generates a small portion of its revenue from Licensing income.

Founded

2018

HQ

Employees

498

Website

lepubiopharma.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: $135M

Net Income: $38M

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Lepu Biopharma Financials

Lepu Biopharma reported last 12-month revenue of $135M.

In the same LTM period, Lepu Biopharma generated $38M in net income.

Lepu Biopharma P&L

In the most recent fiscal year, Lepu Biopharma reported revenue of $54M and EBITDA of ($44M).

Lepu Biopharma expects next 12-month revenue of XXX and NTM EBITDA of XXX

Lepu Biopharma Stock Performance

Lepu Biopharma has current market cap of $1B, and enterprise value of $1B.

Lepu Biopharma's stock price is $0.81.

Lepu Biopharma Valuation Multiples

Lepu Biopharma trades at 11.0x EV/Revenue multiple, and (33.5x) EV/EBITDA.

Lepu Biopharma Financial Valuation Multiples

As of April 19, 2026, Lepu Biopharma has market cap of $1B and EV of $1B.

Equity research analysts estimate Lepu Biopharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Lepu Biopharma has a P/E ratio of 38.8x.

Lepu Biopharma Margins & Growth Rates

Lepu Biopharma's revenue in the last fiscal year grew by 151%.

Lepu Biopharma's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Lepu Biopharma Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Lepu Biopharma M&A Activity

Lepu Biopharma acquired XXX companies to date.

Last acquisition by Lepu Biopharma was on XXXXXXXX, XXXXX. Lepu Biopharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Lepu Biopharma Investment Activity

Lepu Biopharma invested in XXX companies to date.

Lepu Biopharma made its latest investment on XXXXXXXX, XXXXX. Lepu Biopharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).